The DOI matches its Crossref record; 152 of the 154 references it cites were found in a registry or an index.
The Effects of Amiodarone on the Thyroid*
Abstract
Amiodarone is a benzofuranic-derivative iodine-rich drug widely used for the treatment of tachyarrhythmias and, to a lesser extent, of ischemic heart disease. It often causes changes in thyroid function tests (typically an increase in serum T(4) and rT(3), and a decrease in serum T(3), concentrations), mainly related to the inhibition of 5'-deiodinase activity, resulting in a decrease in the generation of T(3) from T(4) and a decrease in the clearance of rT(3). In 14-18% of amiodarone-treated patients, there is overt thyroid dysfunction, either amiodarone-induced thyrotoxicosis (AIT) or amiodarone-induced hypothyroidism (AIH). Both AIT and AIH may develop either in apparently normal thyroid glands or in glands with preexisting, clinically silent abnormalities. Preexisting Hashimoto's thyroiditis is a definite risk factor for the occurrence of AIH. The pathogenesis of iodine-induced AIH is related to a failure to escape from the acute Wolff-Chaikoff effect due to defects in thyroid hormonogenesis, and, in patients with positive thyroid autoantibody tests, to concomitant Hashimoto's thyroiditis. AIT is primarily related to excess iodine-induced thyroid hormone synthesis in an abnormal thyroid gland (type I AIT) or to amiodarone-related destructive thyroiditis (type II AIT), but mixed forms frequently exist. Treatment of AIH consists of L-T(4) replacement while continuing amiodarone therapy; alternatively, if feasible, amiodarone can be discontinued, especially in the absence of thyroid abnormalities, and the natural course toward euthyroidism can be accelerated by a short course of potassium perchlorate treatment. In type I AIT the main medical treatment consists of the simultaneous administration of thionamides and potassium perchlorate, while in type II AIT, glucocorticoids are the most useful therapeutic option. Mixed forms are best treated with a combination of thionamides, potassium perchlorate, and glucocorticoids. Radioiodine therapy is usually not feasible due to the low thyroidal radioiodine uptake, while thyroidectomy can be performed in cases resistant to medical therapy, with a slightly increased surgical risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amiodarone in Patients with Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia
Singh, S. N., Fletcher, R. D., Fisher, S. G., Singh, B. N., Lewis, H. D., Deedwania, P. C., Massie, B. M., Colling, C., & Lazzeri, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507133330201 · Cited by 1,225
Amiodarone to Prevent Recurrence of Atrial Fibrillation
Roy, D., Talajic, M., Dorian, P., Connolly, S., Eisenberg, M. J., Green, M., Kus, T., Lambert, J., Dubuc, M., Gagné, P., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421302 · Cited by 1,143
Randomised trial of low-dose amiodarone in severe congestive heart failure
Doval, H., Nul, D., Grancelli, H., Perrone, S., Bortman, G., & Curiel, R. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91895-3 · Cited by 920
Amiodarone for Resuscitation after Out-of-Hospital Cardiac Arrest Due to Ventricular Fibrillation
Kudenchuk, P. J., Cobb, L. A., Copass, M. K., Cummins, R. O., Doherty, A. M., Fahrenbruch, C. E., Hallstrom, A. P., Murray, W. A., Olsufka, M., & Walsh, T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411203 · Cited by 809
Perchlorate and the Thyroid Gland
Wolff, J. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01350-4 · Cited by 588
Preoperative Amiodarone as Prophylaxis against Atrial Fibrillation after Heart Surgery
Daoud, E. G., Strickberger, S. A., Man, K. C., Goyal, R., Deeb, G. M., Bolling, S. F., Pagani, F. D., Bitar, C., Meissner, M. D., & Morady, F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199712183372501 · Cited by 529
Holt, D. W., Tucker, G. T., Jackson, P. R., & Storey, G. C. A. (1983) · American Heart Journal · doi:10.1016/0002-8703(83)90006-6 · Cited by 410
Environmental Iodine Intake and Thyroid Dysfunction During Chronic Amiodarone Therapy
MARTINO, E., SAFRAN, M., AGHINI-LOMBARDI, F., RAJATANAVIN, R., LENZIARDI, M., FAY, M., PACCHIAROTTI, A., ARONIN, N., MACCHIA, E., HAFFAJEE, C., et al. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-1-28 · Cited by 370
Self-citationPhosphofructokinase deficiency in skeletal muscle. A new type of glycogenosis
Tarui, S., Giichi, O., Ikura, Y., Tanaka, T., Suda, M., & Nishikawa, M. (1965) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(65)90156-7 · Cited by 369
Burger, A., Dinichert, D., Nicod, P., Jenny, M., Lemarchand-Béraud, T., & Vallotton, M. B. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108466 · Cited by 312
Cited by
Thyroid hormone and the cardiovascular system.
Klein, I., & Ojamaa, K. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440707 · Cited by 2,300
Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0455 · Cited by 1,853
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567
“In the presence of other autoimmune disease such as type 1 diabetes (20,21) or Addison’s disease (17,18), chromosomal disorders such as Down’s (30) or Turner’s syndrome (31), and therapy with drugs such as lithium (32–34), interferon alpha (35,36), and amiodarone (37) or excess iodine ingestion (e.”
Global epidemiology of hyperthyroidism and hypothyroidism
Taylor, P. N., Albrecht, D., Scholz, A., Gutierrez-Buey, G., Lazarus, J. H., Dayan, C. M., & Okosieme, O. E. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2018.18 · Cited by 1,552
Klein, I., & Danzi, S. (2007) · Circulation · doi:10.1161/circulationaha.106.678326 · Cited by 1,324
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber for the American Association, K. A. (2012) · Thyroid · doi:10.1089/thy.2012.0205 · Cited by 1,053
Pearce, E. N., Farwell, A. P., & Braverman, L. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021194 · Cited by 878
Self-citationThe Sodium/Iodide Symporter (NIS): Characterization, Regulation, and Medical Significance
Dohán, O., De la Vieja, A., Paroder, V., Riedel, C., Artani, M., Reed, M., Ginter, C. S., & Carrasco, N. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0029 · Cited by 861
Deiodinases: implications of the local control of thyroid hormone action
Bianco, A. C., & Kim, B. W. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29812 · Cited by 845
Thyroid dysfunction and kidney disease
Iglesias, P., & Díez, J. J. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0837 · Cited by 442
Tomer, Y., & Davies, T. F. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0030 · Cited by 422
Basaria, S., & Cooper, D. S. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.11.028 · Cited by 346
Thyroid hormones states and brain development interactions
Ahmed, O. M., El‐Gareib, A. W., El‐bakry, A. M., Abd El‐Tawab, S. M., & Ahmed, R. G. (2008) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2007.09.011 · Cited by 341
Daştan, A., Kulkarni, A., & Török, B. (2011) · Green Chemistry · doi:10.1039/c1gc15837f · Cited by 273
Bartalena, L., Bogazzi, F., Chiovato, L., Hubalewska-Dydejczyk, A., Links, T. P., & Vanderpump, M. (2018) · European Thyroid Journal · doi:10.1159/000486957 · Cited by 264
Self-citationTreatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259
A Practical Guide for Clinicians Who Treat Patients with Amiodarone: 2007
Goldschlager, N., Epstein, A. E., Naccarelli, G. V., Olshansky, B., Singh, B., Collard, H. R., & Murphy, E. (2007) · Heart Rhythm · doi:10.1016/j.hrthm.2007.07.020 · Cited by 256
Klein, I., & Danzi, S. (2016) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2015.04.002 · Cited by 218
Hypothyroidism: etiology, diagnosis, and management
Almandoz, J. P., & Gharib, H. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.01.005 · Cited by 216
Hashimotos Thyroiditis: From Genes to the Disease
Zaletel, K., & Gaberscek, S. (2011) · Current Genomics · doi:10.2174/138920211798120763 · Cited by 210
Thyroid Hormone Plays an Important Role in Cardiac Function: From Bench to Bedside
Yamakawa, H., Kato, T., Noh, J. Y., Yuasa, S., Kawamura, A., Fukuda, K., & Aizawa, Y. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.606931 · Cited by 210
Gereben, B., Zeöld, A., Dentice, M., Salvatore, D., & Bianco, A. C. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7396-0 · Cited by 207
Approach to the Patient with Amiodarone-Induced Thyrotoxicosis
Bogazzi, F., Bartalena, L., & Martino, E. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0180 · Cited by 206
Self-citationHyperthyroidism and Thyrotoxicosis
Devereaux, D. C., & Tewelde, S. Z. (2014) · Emergency Medicine Clinics of North America · doi:10.1016/j.emc.2013.12.001 · Cited by 192
Thyroid Hormone and the Cardiovascular System
Danzi, S., & Klein, I. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.01.006 · Cited by 172
Thyroid Physiology and Diagnostic Evaluation of Patients with Thyroid Disorders
Salvatore, D., Davies, T. F., Schlumberger, M.-J., HAY, I. D., & Larsen, P. R. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00011-0 · Cited by 172
Burch, H. B. (2019) · New England Journal of Medicine · doi:10.1056/nejmra1901214 · Cited by 164
The Various Effects of Amiodarone on Thyroid Function
Bogazzi, F., Bartalena, L., Gasperi, M., Braverman, L. E., & Martino, E. (2001) · Thyroid · doi:10.1089/105072501300176471 · Cited by 160
Self-citationImatinib induces hypothyroidism in patients receiving levothyroxine
DEGROOT, J., ZONNENBERG, B., PLUKKER, J., VANDERGRAAF, W., & LINKS, T. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.06.010 · Cited by 159
Effects of amiodarone therapy on thyroid function
Cohen-Lehman, J., Dahl, P., Danzi, S., & Klein, I. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.225 · Cited by 157
“At a standard dose of 100–600 mg per day, therefore, recipients are exposed to 3–21 mg iodine per day, which is over 35–140 times the recommended daily allowance of iodide (150 µg per day)”
BackgroundHypothyroidism in the Elderly: Pathophysiology, Diagnosis and Treatment
Laurberg, P., Andersen, S., Pedersen, I. B., & Carl, A. B. (2005) · Drugs & Aging · doi:10.2165/00002512-200522010-00002 · Cited by 154
(CONTAM), E. P. O. C. I. T. F. C. (2014) · EFSA Journal · doi:10.2903/j.efsa.2014.3869 · Cited by 153
Dahl, P., Danzi, S. E., & Klein, I. L. (2008) · Current Heart Failure Reports · doi:10.1007/s11897-008-0026-9 · Cited by 149
Amiodarone and the thyroid: a 2012 update.
Bogazzi, F., Tomisti, L., Bartalena, L., Aghini-Lombardi, F., & Martino, E. (2012) · PubMed · doi:10.3275/8298 · Cited by 149
Self-citationEskes, S. A., & Wiersinga, W. M. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.07.001 · Cited by 148
Eaton, S. E. M., Euinton, H. A., Newman, C. M., Weetman, A. P., & Bennet, W. M. (2002) · Clinical Endocrinology · doi:10.1046/j.0300-0664.2001.01457.x · Cited by 139
Deiodinases control local cellular and systemic thyroid hormone availability
Köhrle, J., & Frädrich, C. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.09.024 · Cited by 133
Depressogenic effects of medications: a review
Celano, C. M., Freudenreich, O., Fernandez-Robles, C. G., Stern, T. A., Caro, M. A., & Huffman, J. C. (2011) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2011.13.1/ccelano · Cited by 128
Neuropsychiatric consequences of cardiovascular medications
Huffman, J. C., & Stern, T. A. (2007) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2007.9.1/jchuffman · Cited by 128
Time‐to‐onset analysis of amiodarone‐associated thyroid dysfunction
Kinoshita, S., Hosomi, K., Yokoyama, S., & Takada, M. (2019) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.13024 · Cited by 126
Hypothyroidism and Thyroiditis
Brent, G. A., & Davies, T. F. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00013-4 · Cited by 126
Practical Management Guide for Clinicians Who Treat Patients with Amiodarone
Epstein, A. E., Olshansky, B., Naccarelli, G. V., Kennedy, J. I., Murphy, E. J., & Goldschlager, N. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2015.08.039 · Cited by 125
Thyroid Autoantibodies in Pregnancy: Their Role, Regulation and Clinical Relevance
Balucan, F. S., MORSHED, S. A., & Davies, T. F. (2013) · Journal of Thyroid Research · doi:10.1155/2013/182472 · Cited by 125
Amiodarone and thyroid physiology, pathophysiology, diagnosis and management
Trohman, R. G., Sharma, P. S., McAninch, E. A., & Bianco, A. C. (2018) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2018.09.005 · Cited by 123
Amiodarone-induced thyrotoxicosis: A review
Tsang, W., & Houlden, R. L. (2009) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(09)70512-4 · Cited by 123
Perchlorate Clinical Pharmacology and Human Health: A Review
Soldin, O. P., Braverman, L. E., & Lamm, S. H. (2001) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200108000-00002 · Cited by 118
Self-citationThyroid Function Abnormalities during Amiodarone Therapy for Persistent Atrial Fibrillation
Batcher, E. L., Tang, X. C., Singh, B. N., Singh, S. N., Reda, D. J., & Hershman, J. M. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.04.022 · Cited by 116
Physiological role and regulation of iodothyronine deiodinases: A 2011 update
Marsili, A., Zavacki, A. M., Harney, J. W., & Larsen, P. R. (2011) · Journal of Endocrinological Investigation · doi:10.1007/bf03347465 · Cited by 113
Pearce, E. N., Bogazzi, F., Martino, E., Brogioni, S., Pardini, E., Pellegrini, G., Parkes, A. B., Lazarus, J. H., Pinchera, A., & Braverman, L. E. (2003) · Thyroid · doi:10.1089/105072503322239989 · Cited by 113
Self-citationManagement of amiodarone-related thyroid problems
Narayana, S. K., Woods, D. R., & Boos, C. J. (2011) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018811398516 · Cited by 108
Surgical Management of Amiodarone‐associated Thyrotoxicosis: Mayo Clinic Experience
Houghton, S. G., Farley, D. R., Brennan, M. D., van Heerden, J. A., Thompson, G. B., & Grant, C. S. (2004) · World Journal of Surgery · doi:10.1007/s00268-004-7599-6 · Cited by 103
Raldúa, D., & Babin, P. J. (2009) · Environmental Science & Technology · doi:10.1021/es9012454 · Cited by 103
Adverse reactions of Amiodarone.
Biancatelli, R. M. L. C., Congedo, V., Calvosa, L., Ciacciarelli, M., Polidoro, A., & Iuliano, L. (2019) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2019.07.004 · Cited by 102
Dighe, M., Barr, R., Bojunga, J., Cantisani, V., Chammas, M. C., Cosgrove, D. O., Cui, X. W., Dong, Y., Fenner, F., Radziņa, M., et al. (2017) · Medical Ultrasonography · doi:10.11152/mu-980 · Cited by 100
Successful Treatment of Amiodarone-Induced Thyrotoxicosis
Osman, F., Franklyn, J. A., Sheppard, M. C., & Gammage, M. D. (2002) · Circulation · doi:10.1161/circ.105.11.1275 · Cited by 96
Amiodarone: an effective antiarrhythmic drug with unusual side effects
ERVEN, L. V., & Schalij, M. J. (2010) · Heart · doi:10.1136/hrt.2008.152652 · Cited by 95
O’Sullivan, A., Lewis, M., & Diamond, T. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02122 · Cited by 92
Bogazzi, F., Bartalena, L., Cosci, C., Brogioni, S., Dell'Unto, E., Grasso, L., Aghini-Lombardi, F., Rossi, G., Pinchera, A., Braverman, L. E., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021874 · Cited by 92
Self-citationPiga, M., Cocco, M. C., Serra, A., Boi, F., Loy, M., & Mariotti, S. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0348 · Cited by 90
Bartalena, L., Wiersinga, W. M., Tanda, M. L., Bogazzi, F., Piantanida, E., Lai, A., & Martino, E. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02119.x · Cited by 90
Self-citationComplex Drug-Drug-Disease Interactions Between Amiodarone, Warfarin, and the Thyroid Gland
Kurnik, D., Loebstein, R., Farfel, Z., Ezra, ., Halkin, H., & Olchovsky, D. (2004) · Medicine · doi:10.1097/01.md.0000123095.65294.34 · Cited by 89
Amiodarone-Induced Thyrotoxicosis
Conen, D., Melly, L., Kaufmann, C. C., Bilz, S., Ammann, P., Schaer, B. A., Sticherling, C., Müller-Stich, B. P., & Osswald, S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.054 · Cited by 88
Treatment of Graves' Hyperthyroidism: Evidence-Based and Emerging Modalities
Hegedűs, L. D. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2009.01.009 · Cited by 85
Bogazzi, F., Bartalena, L., Tomisti, L., Rossi, G., Tanda, M. L., Dell'Unto, E., Aghini-Lombardi, F., & Martino, E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2059 · Cited by 84
Self-citationTanda, M. L., Piantanida, E., Lai, A., Liparulo, L., Sassi, L., Bogazzi, F., Wiersinga, W. M., Braverman, L. E., Martino, E., & Bartalena, L. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03268.x · Cited by 83
Self-citationInhibition of Amiodarone‐Induced Lung Fibrosis but not Alveolitis by Angiotensin System Antagonists
Uhal, B. D., Wang, R., Laukka, J. J., Zhuang, J., Soledad‐Conrad, V., & Filippatos, G. S. (2003) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2003.920204.x · Cited by 82
Rhabdomyolysis in Association with Simvastatin and Amiodarone
Roten, L., Schoenenberger, R. A., Krähenbühl, S., & Schlienger, R. G. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d498 · Cited by 78
Evaluation and Treatment of Amiodarone-Induced Thyroid Disorders
Ylli, D., Wartofsky, L., & Burman, K. D. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa686 · Cited by 76
Amiodarone-Induced Thyroid Dysfunction
Danzi, S. E., & Klein, I. L. (2013) · Journal of Intensive Care Medicine · doi:10.1177/0885066613503278 · Cited by 76
Critical issues in endocrinology
Goldberg, P. A., & Inzucchi, S. E. (2003) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(03)00091-1 · Cited by 76
Bogazzi, F., Bartalena, L., Dell'Unto, E., Tomisti, L., Rossi, G., Pepe, P., Tanda, M. L., Grasso, L., Macchia, E., Aghini-Lombardi, F., et al. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02920.x · Cited by 76
Self-citationTomisti, L., Materazzi, G., Bartalena, L., Rossi, G., Marchello, A., Moretti, M., De Napoli, L., Mariotti, R., Miccoli, P., Martino, E., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1797 · Cited by 75
“Two main forms of amiodaroneinduced thyrotoxicosis (AIT) are well recognized: type 1 AIT is a true form of iodine-induced hyperthyroidism in a diseased gland (nodular goiter or latent Graves’ disease), whereas type 2 AIT is an amiodarone-induced destructive thyroiditis occurring in a normal thyroid gland (1, 3, 4).”
BackgroundSelf-citationEffects of Chronic Iodine Excess in a Cohort of Long-Term American Workers in West Africa
Pearce, E. N., Gerber, A. R., Gootnick, D. B., Khan, L. K., Li, R., Pino, S., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020692 · Cited by 75
Self-citationPayne, S. L., Ram, P., Srinivasan, D. H., Le, T. T., Levin, M. G., & Oudin, M. J. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103767 · Cited by 74
Benzofuran derivatives and the thyroid
Han, T. S., Williams, G. R., & Vanderpump, M. P. J. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03350.x · Cited by 74
Rosene, M. L., Wittmann, G., Arrojo e Drigo, R., Singru, P. S., Lechan, R. M., & Bianco, A. C. (2010) · Endocrinology · doi:10.1210/en.2010-0553 · Cited by 72
Ahmed, S., Van Gelder, I. C., Wiesfeld, A. C. P., Van Veldhuisen, D. J., & Links, T. P. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04087.x · Cited by 72
Bogazzi, F., Martino, E., Dell’Unto, E., Brogioni, S., Cosci, C., Aghini-Lombardi, F., Ceccarelli, C., Pinchera, A., Bartalena, L., & Braverman, L. E. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03347021 · Cited by 71
Self-citationTotal Thyroidectomy for Amiodarone‐associated Thyrotoxicosis in Patients with Severe Cardiac Disease
Gough, J., & Gough, I. R. (2006) · World Journal of Surgery · doi:10.1007/s00268-005-0673-x · Cited by 70
Tireotoxicose Induzida pela Amiodarona - Revisão de Literatura e Atualização Clínica
de Souza, L. V. F., Campagnolo, M. T., Martins, L. C. B., & Scanavacca, M. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20190757 · Cited by 69
Amiodarone and Thyroid Dysfunction
Medić, F. (2022) · Acta Clinica Croatica · doi:10.20471/acc.2022.61.02.20 · Cited by 68
Environmental factors and thyroid autoimmunity
Duntas, L. H. (2011) · Annales d Endocrinologie · doi:10.1016/j.ando.2011.03.019 · Cited by 68
Bogazzi, F., Tomisti, L., Rossi, G., Dell'Unto, E., Pepe, P., Bartalena, L., & Martino, E. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0940 · Cited by 66
Self-citationBogazzi, F., Miccoli, P., Berti, P., Cosci, C., Brogioni, S., Aghini-Lombardi, F., Materazzi, G., Bartalena, L., Pinchera, A., Braverman, L. E., et al. (2002) · Surgery · doi:10.1067/msy.2002.128561 · Cited by 66
Self-citationIodine-Induced Thyroid Disease
Wiersinga, W. M., & Braverman, L. E. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-352-1_17 · Cited by 66
Self-citationMicrowave-Assisted Synthesis of Five-MemberedO-Heterocycles
Kaur, N. (2014) · Synthetic Communications · doi:10.1080/00397911.2013.800213 · Cited by 64
Clinical review: thyroid hormone replacement in children after cardiac surgery--is it worth a try?
Haas, N. A., Camphausen, C. K., & Kececioglu, D. (2006) · Critical Care · doi:10.1186/cc4924 · Cited by 64
Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis
Cappellani, D., Papini, P., Pingitore, A., Tomisti, L., Mantuano, M., Certo, A. M. D., Manetti, L., Marconcini, G., Scattina, I., Urbani, C., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz041 · Cited by 61
Self-citationThe onset time of amiodarone-induced thyrotoxicosis (AIT) depends on AIT type
Tomisti, L., Rossi, G., Bartalena, L., Martino, E., & Bogazzi, F. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0267 · Cited by 60
Self-citationAmiodarone‐induced thyrotoxicosis: a difficult diagnostic and therapeutic challenge*
Bartalena, L., Bogazzi, F., & Martino, E. (2002) · Clinical Endocrinology · doi:10.1046/j.0300-0664.2001.01458.x · Cited by 60
Self-citationBogazzi, F., Bartalena, L., Tomisti, L., Rossi, G., Brogioni, S., & Martino, E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1678 · Cited by 59
Self-citationAmiodarone and Thyroid Dysfunction
Padmanabhan, H. (2010) · Southern Medical Journal · doi:10.1097/smj.0b013e3181e90500 · Cited by 58
Thyrotoxicosis and thyroiditis
Yap, P. S., Ali, O., Truran, P., & Aspinall, S. R. (2020) · Surgery (Oxford) · doi:10.1016/j.mpsur.2020.10.002 · Cited by 57
Amiodarone Therapy: Updated Practical Insights
Șorodoc, V., Indrei, L., Dobroghii, C., Asaftei, A., Ceasovschih, A., Constantin, M., Lionte, C., Morărașu, B. C., Diaconu, A.-D., & Șorodoc, L. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206094 · Cited by 58
Loy, M., Perra, E., Melis, A., Cianchetti, M. E., Piga, M., Serra, A., Pinna, G., & Mariotti, S. (2007) · Acta Radiologica · doi:10.1080/02841850701342138 · Cited by 55
The role of TSH receptor antibodies in the management of Graves' disease
Matthews, D. C., & Syed, A. A. (2011) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2011.02.006 · Cited by 55
Assay of Thyroid Hormones and Related Substances
Spencer, C. A. (2013) · Europe PMC (PubMed Central) · Cited by 54
Thyroid Physiology and Diagnostic Evaluation of Patients With Thyroid Disorders
Salvatore, D., Davies, T. F., Schlumberger, M.-J., HAY, I. D., & Larsen, P. R. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00011-3 · Cited by 53
Long-term lithium treatment and thyroid antibodies: a controlled study
Baethge, C., Blumentritt, H., Berghöfer, A., Bschor, T., Glenn, T., Adli, M., Schlattmann, P., Bauer, M., & Finke, R. (2005) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0554 · Cited by 53
Sanctis, V. D., Soliman, A. T., Canatan, D., Yassin, M. A., Daar, S., Elsedfy, H., Maio, S. D., Raiola, G., Corrons, J.-L. V., & Kattamis, C. (2019) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2019.029 · Cited by 53
Metadata
- Authors
- Martino, E., Bartalena, L., Bogazzi, F., & Braverman, L. E.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2001-04-01
- Volume
- 22
- Issue
- 2
- Pages
- 240-254
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2117317136
- Cited by
- 551
- References
- 154
- FWCI
- 14.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.